RxDoctor Payments Data

Bard Silicone Uretero-Intestinal Anastomosis Urinary Diversion Stent: payments to doctors

Payments that named Bard Silicone Uretero-Intestinal Anastomosis Urinary Diversion Stent as the associated device or medical supply, reported under the Sunshine Act for program years 20192025.

Was your doctor paid by C. R. Bard, Inc. & Subsidiaries?

C. R. Bard, Inc. & Subsidiaries reported the most payments naming Bard Silicone Uretero-Intestinal Anastomosis Urinary Diversion Stent. Search your clinician to see whether they are among them — and what else they were paid for.

Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.

Total reported
$118K
Providers
12
Transactions
13
Average per transaction
$9,106

The per-transaction average — $9,106 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 12 providers the average total is $9,865, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
C. R. Bard, Inc. & Subsidiaries$118,382100.0%

Other products from C. R. Bard, Inc. & Subsidiaries

The company that reported the most payments naming Bard Silicone Uretero-Intestinal Anastomosis Urinary Diversion Stent also reports against these.

← All drugs & devices